142 related articles for article (PubMed ID: 15055989)
21. Synthesis and evaluation of aza-peptidyl inhibitors of the lysosomal asparaginyl endopeptidase, legumain.
Lee J; Bogyo M
Bioorg Med Chem Lett; 2012 Feb; 22(3):1340-3. PubMed ID: 22243962
[TBL] [Abstract][Full Text] [Related]
22. Peptidyl allyl sulfones: a new class of inhibitors for clan CA cysteine proteases.
Götz MG; Caffrey CR; Hansell E; McKerrow JH; Powers JC
Bioorg Med Chem; 2004 Oct; 12(19):5203-11. PubMed ID: 15351403
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of papain-like cysteine proteases and legumain by caspase-specific inhibitors: when reaction mechanism is more important than specificity.
Rozman-Pungercar J; Kopitar-Jerala N; Bogyo M; Turk D; Vasiljeva O; Stefe I; Vandenabeele P; Brömme D; Puizdar V; Fonović M; Trstenjak-Prebanda M; Dolenc I; Turk V; Turk B
Cell Death Differ; 2003 Aug; 10(8):881-8. PubMed ID: 12867995
[TBL] [Abstract][Full Text] [Related]
24. Michael acceptors as cysteine protease inhibitors.
Santos MM; Moreira R
Mini Rev Med Chem; 2007 Oct; 7(10):1040-50. PubMed ID: 17979807
[TBL] [Abstract][Full Text] [Related]
25. Aza-peptidyl Michael acceptor and epoxide inhibitors--potent and selective inhibitors of Schistosoma mansoni and Ixodes ricinus legumains (asparaginyl endopeptidases).
Ovat A; Muindi F; Fagan C; Brouner M; Hansell E; Dvorák J; Sojka D; Kopácek P; McKerrow JH; Caffrey CR; Powers JC
J Med Chem; 2009 Nov; 52(22):7192-210. PubMed ID: 19848405
[TBL] [Abstract][Full Text] [Related]
26. Aziridinyl peptides as inhibitors of cysteine proteases: effect of a free carboxylic acid function on inhibition.
Schirmeister T; Peric M
Bioorg Med Chem; 2000 Jun; 8(6):1281-91. PubMed ID: 10896108
[TBL] [Abstract][Full Text] [Related]
27. Structural basis of inhibition of cysteine proteases by E-64 and its derivatives.
Matsumoto K; Mizoue K; Kitamura K; Tse WC; Huber CP; Ishida T
Biopolymers; 1999; 51(1):99-107. PubMed ID: 10380357
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and evaluation of peptidyl Michael acceptors that inactivate human rhinovirus 3C protease and inhibit virus replication.
Kong JS; Venkatraman S; Furness K; Nimkar S; Shepherd TA; Wang QM; Aubé J; Hanzlik RP
J Med Chem; 1998 Jul; 41(14):2579-87. PubMed ID: 9651162
[TBL] [Abstract][Full Text] [Related]
29. Highly selective azadipeptide nitrile inhibitors for cathepsin K: design, synthesis and activity assays.
Ren XF; Li HW; Fang X; Wu Y; Wang L; Zou S
Org Biomol Chem; 2013 Feb; 11(7):1143-8. PubMed ID: 23299878
[TBL] [Abstract][Full Text] [Related]
30. The Bsmoc group as a novel scaffold for the design of irreversible inhibitors of cysteine proteases.
Iley J; Moreira R; Martins L; Guedes RC; Soares CM
Bioorg Med Chem Lett; 2006 May; 16(10):2738-41. PubMed ID: 16503139
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and biological evaluation of reversible inhibitors of IdeS, a bacterial cysteine protease and virulence determinant.
Berggren K; Johansson B; Fex T; Kihlberg J; Björck L; Luthman K
Bioorg Med Chem; 2009 May; 17(9):3463-70. PubMed ID: 19362485
[TBL] [Abstract][Full Text] [Related]
32. New m-calpain substrate-based azapeptide inhibitors.
Bánóczi Z; Tantos Á; Farkas A; Majer Z; Dókus LE; Tompa P; Hudecz F
J Pept Sci; 2013 Jun; 19(6):370-6. PubMed ID: 23613308
[TBL] [Abstract][Full Text] [Related]
33. "Click" synthesis of small molecule-peptide conjugates for organelle-specific delivery and inhibition of lysosomal cysteine proteases.
Loh Y; Shi H; Hu M; Yao SQ
Chem Commun (Camb); 2010 Nov; 46(44):8407-9. PubMed ID: 20931108
[TBL] [Abstract][Full Text] [Related]
34. The inhibitor profiling of the caspase family of proteases using substrate-derived peptide glyoxals.
Murphy DJ; Walker B; Ryan CA; Martin SL
Biochem Biophys Res Commun; 2010 Nov; 402(3):483-8. PubMed ID: 20955686
[TBL] [Abstract][Full Text] [Related]
35. Optimization of peptidyl allyl sulfones as clan CA cysteine protease inhibitors.
Fennell BD; Warren JM; Chung KK; Main HL; Arend AB; Tochowicz A; Götz MG
J Enzyme Inhib Med Chem; 2013 Jun; 28(3):468-78. PubMed ID: 22380780
[TBL] [Abstract][Full Text] [Related]
36. Evolutionary lines of cysteine peptidases.
Barrett AJ; Rawlings ND
Biol Chem; 2001 May; 382(5):727-33. PubMed ID: 11517925
[TBL] [Abstract][Full Text] [Related]
37. Novel azapeptide inhibitors of hepatitis C virus serine protease.
Bailey MD; Halmos T; Goudreau N; Lescop E; Llinàs-Brunet M
J Med Chem; 2004 Jul; 47(15):3788-99. PubMed ID: 15239657
[TBL] [Abstract][Full Text] [Related]
38. Novel peptidomimetic cysteine protease inhibitors as potential antimalarial agents.
Micale N; Kozikowski AP; Ettari R; Grasso S; Zappalà M; Jeong JJ; Kumar A; Hanspal M; Chishti AH
J Med Chem; 2006 Jun; 49(11):3064-7. PubMed ID: 16722625
[TBL] [Abstract][Full Text] [Related]
39. Inactivation of cysteine proteases.
Govardhan CP; Abeles RH
Arch Biochem Biophys; 1996 Jun; 330(1):110-4. PubMed ID: 8651683
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
